Medco Drug Withdrawal Response Shows Value Of Patient Data, Exec Says
Executive Summary
Merck-Medco sent over 233,000 letters to patients and 81,000 letters to physicians during the June 1998 withdrawals of Posicor and Duract, Merck-Medco Senior VP Terry Latanich told a House Commerce/Health and Environment Subcommittee hearing on medical records confidentiality May 27.